TY - JOUR
T1 - Common clinical features and disease mechanisms of psoriasis and psoriatic arthritis.
AU - Myers, Wendy
AU - Opeola, Mobolaji
AU - Gottlieb, Alice B.
N1 - Funding Information:
This work was funded in part by grants from the David Ju Foundation and a Center of Excellence Award by the Federation of Clinical Immunology Societies.
PY - 2004/8
Y1 - 2004/8
N2 - Psoriasis and psoriatic arthritis are chronic inflammatory diseases that significantly affect patients' quality of life. Not only do these diseases impact patients' physical well-being, but also detrimentally affect their life socially and psychologically. There are many different patterns of skin and joint involvement. Understanding the pathogenesis of these diseases has evolved greatly in the past few decades. It is now understood that psoriasis and psoriatic arthritis are T cell mediated disorders. A number of proinflammatory cytokines have been suggested as playing a role in the disease mechanism, such as tumor necrosis factor-alpha and interferon-gamma. Other important factors proposed in the pathogenesis of these diseases include the role of genetics and environmental factors. New immunomodulating therapies, which are being developed as our understanding of the involvement of innate and adaptive immunity advances, will provide patients with safer, more effective, long-term, management options.
AB - Psoriasis and psoriatic arthritis are chronic inflammatory diseases that significantly affect patients' quality of life. Not only do these diseases impact patients' physical well-being, but also detrimentally affect their life socially and psychologically. There are many different patterns of skin and joint involvement. Understanding the pathogenesis of these diseases has evolved greatly in the past few decades. It is now understood that psoriasis and psoriatic arthritis are T cell mediated disorders. A number of proinflammatory cytokines have been suggested as playing a role in the disease mechanism, such as tumor necrosis factor-alpha and interferon-gamma. Other important factors proposed in the pathogenesis of these diseases include the role of genetics and environmental factors. New immunomodulating therapies, which are being developed as our understanding of the involvement of innate and adaptive immunity advances, will provide patients with safer, more effective, long-term, management options.
UR - http://www.scopus.com/inward/record.url?scp=17144362587&partnerID=8YFLogxK
U2 - 10.1007/s11926-004-0043-y
DO - 10.1007/s11926-004-0043-y
M3 - Review article
C2 - 15251083
AN - SCOPUS:17144362587
SN - 1523-3774
VL - 6
SP - 306
EP - 313
JO - Current Rheumatology Reports
JF - Current Rheumatology Reports
IS - 4
ER -